From: O213. Low-level viraemia during treatment with darunavir/r monotherapy versus DRV/r + 2NRTIs in the MONET trial
HIV RNA
DRV/r mono (n=105)
DRV/r + 2NRTIs (n=114
HIV RNA <50, OD = background
79.0%
80.7%
HIV RNA <50, detectable
17.1%
14.9%
HIV RNA 50-400 copies/mL
2.9%
3.5%
HIV RNA <400 copies/mL
1.0%
0.9%